Clinical Trials Directory

Trials / Completed

CompletedNCT06036888

DEFILE-QoL5 - Evaluation of the Long-term Surgical Management of the Thoraco-brachial Displacement Syndrome

DEFILE-QoL5 - Evaluation de la Prise en Charge Chirurgicale à 5 Ans du Syndrome du défilé Thoraco-brachial

Status
Completed
Phase
Study type
Observational
Enrollment
53 (actual)
Sponsor
University Hospital, Angers · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study concerns patients hospitalized in vascular and thoracic surgery in 2016 at the University Hospital of Angers for the management of a thoraco-brachial outlet syndrome. It includes all vascular and neurological manifestations related to intermittent or permanent compression of the vasculo-nervous bundle of the upper limb. Before and after the operation, these patients had agreed to complete the quality of life questionnaires, the Disabilities of the Arm, Shoulder and Hand questionary (DASH) and the Short-Form 12 (SF-12). The objective of the present study is to evaluate the long-term quality of life, using the questionnaires mentioned above, completed by 54 patients treated surgically for thoraco-brachial outlet syndrome and who participated in the DEFILE-QoL study in 2016.

Detailed description

All patients included in the DEFILE-QoL study (in 2016) receive an information letter. Without opposition from them after 4 weeks, they are contacted by telephone. The telephone interview begins with an explanation of the study and a time to answer any questions from the patient. If they agree to participate, they answer the DASH and the SF-12 questionnaires, for an estimated duration of 15 minutes. Following the telephone interview, the patient's participation in the study was terminated. The date of the information and the patient's non-objection are documented in the patient's source file.

Conditions

Interventions

TypeNameDescription
OTHERquestionaries completionAnswer to the DASH and SF-12 questionaries, for an estimated duration of 15 minutes.

Timeline

Start date
2023-11-06
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2023-09-14
Last updated
2026-04-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06036888. Inclusion in this directory is not an endorsement.